Suchergebnisse - "Fullerton, Aaron"

PubPharm (7)

1

A BCMA/CD16A bispecific innate cell engager for the treatment of multiple myeloma

enthalten in: Leukemia | 2022

von Kakiuchi-Kiyota, S. | Ross, T. | Wallweber, H. | +27

2

Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 2 : Improvement of In Vitro Antiproliferation Activity and In Vivo Antitumor Efficacy

enthalten in: Journal of medicinal chemistry | 2021

von Dragovich, P. | Pillow, T. | Blake, R. | +34

3

In vitro assessment of farnesoid X receptor antagonism to predict drug-induced liver injury risk

enthalten in: Archives of toxicology | 2020

von Norona, L. | Fullerton, A. | Lawson, C. | +6

4

An in vitro quantitative systems pharmacology approach for deconvolving mechanisms of drug-induced, multilineage cytopenias

enthalten in: PLoS computational biology | 2020

von Wilson, J. | Lu, D. | Corr, N. | +2

5

General Principles for the Validation of Proarrhythmia Risk Prediction Models : An Extension of the CiPA In Silico Strategy

enthalten in: Clinical pharmacology and therapeutics | 2020

von Li, Z. | Mirams, G. | Yoshinaga, T. | +39

6

Sequential azacitidine and lenalidomide for patients with relapsed and refractory acute myeloid leukemia : Clinical results and predictive modeling using computational analysis

enthalten in: Leukemia research | 2019

von Stevens, B. | Winters, A. | Gutman, J. | +15

7

Proof of Concept for an Automated Image Analysis Method to Quantify Rat Bone Marrow Hematopoietic Lineages on H&E Sections

enthalten in: Toxicologic pathology | 2018

von Kozlowski, C. | Fullerton, A. | Cain, G. | +3

ErratumIn: Toxicol Pathol. 2018 Aug;46(6):722. - PMID 30071760

1
[1]